1-6 of 6
Peronne Joseph
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer

Ramachandra Katabathula, Peronne Joseph, Salendra Singh, Songzhu Zhao, Bhavna Kumar, Patricia Gaule, Quintin Pan, Matthew Old, David P. Tuck, Vinay Varadan
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 984–992.
https://doi.org/10.1158/1078-0432.CCR-21-1978
Published: 03 March 2022
View article titled, Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer
Open the PDF for Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Mitotic Exit Dysfunction through the Deregulation of APC/C Characterizes Cisplatin-Resistant State in Epithelial Ovarian Cancer

Anil Belur Nagaraj, Olga Kovalenko, Rita Avelar, Peronne Joseph, Annalyn Brown, Arshia Surti, Sandra Mantilla, Analisa DiFeo
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (18): 4588–4601.
https://doi.org/10.1158/1078-0432.CCR-17-2885
Published: 14 September 2018
View article titled, Mitotic Exit Dysfunction through the Deregulation of APC/C Characterizes Cisplatin-Resistant State in Epithelial Ovarian Cancer
Open the PDF for Mitotic Exit Dysfunction through the Deregulation of APC/C Characterizes Cisplatin-Resistant State in Epithelial Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B66: miRNA 3’UTR activity driven enrichment of ovarian tumor-initiating cells (TICs) to overcome the barriers of heterogeneity and TIC plasticity

Anil Belur Nagaraj, Peronne Joseph, Matthew Knarr, Olga Kovalenko, Arshia Surti, Analisa DiFeo
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15_Supplement): B66.
https://doi.org/10.1158/1557-3265.OVCA17-B66
Published: 01 August 2018
View article titled, Abstract B66: miRNA 3’UTR activity driven enrichment of ovarian tumor-initiating cells (TICs) to overcome the barriers of heterogeneity and TIC plasticity
Journal Articles

Abstract NTOC-081: PHARMACOLOGIC ANALYSIS OF HIGH–GRADE SEROUS OVARIAN CANCER TCGA DATASET IDENTIFIES A NOVEL CHEMO–ADJUVANT ROLE FOR NON–STEROIDAL ANTI–INFLAMMATORY DRUGS (NSAIDS)

Anil Belur Nagaraj, QuanQiu Wang, Olga Kovalenko, Peronne Joseph, Yang Chen, Rong Xu, Analisa DiFeo
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): NTOC-081.
https://doi.org/10.1158/1557-3265.OVCASYMP16-NTOC-081
Published: 31 May 2017
View article titled, Abstract NTOC-081: PHARMACOLOGIC ANALYSIS OF HIGH–GRADE SEROUS OVARIAN CANCER TCGA DATASET IDENTIFIES A NOVEL CHEMO–ADJUVANT ROLE FOR NON–STEROIDAL ANTI–INFLAMMATORY DRUGS (NSAIDS)
Journal Articles

Abstract A64: β-catenin as a TIC therapeutic target in epithelial ovarian cancer.

Anil Belur Nagaraj, Peronne Joseph, Olga Kovalenko, Sareena Singh, Amy Armstrong, Analisa DiFeo.
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): A64.
https://doi.org/10.1158/1557-3265.OVCA15-A64
Published: 15 January 2016
View article titled, Abstract A64: β-catenin as a TIC therapeutic target in epithelial ovarian cancer.
Journal Articles

Abstract B47: microRNA-181a plays a critical role in ovarian cancer progression through the regulation of epithelial-mesenchymal transition

Aditya Parikh, Christine Lee, Peronne Joseph, Sergio Marchini, Alessia Baccarini, Valentin Kolev, Chiara Romualdi, Robert Fruscio, Hardik Shah, Wang Feng, Gavriel Mullokandov, David Fishman, Maurizio D'Incalci, Jamal Rahaman, Tamara Kalir, Raymond Redline, Brian D. Brown, Goutham Narla, Analisa DiFeo
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): B47.
https://doi.org/10.1158/1078-0432.OVCA13-B47
Published: 13 May 2014
View article titled, Abstract B47: microRNA-181a plays a critical role in ovarian cancer progression through the regulation of epithelial-mesenchymal transition